- Title
- Medication-related problems in outpatients with decompensated cirrhosis: opportunities for harm prevention
- Creator
- Hayward, Kelly L.; Patel, Preya J.; Martin, Jennifer H.; Powell, Elizabeth E.; Valery, Patricia C.; Horsfall, Leigh U.; Li, Catherine Y.; Wright, Penny L.; Tallis, Caroline J.; Stuart, Katherine A.; Irvine, Katharine M.; Cottrell, W. Neil
- Relation
- Hepatology Communications Vol. 3, Issue 5, p. 620-631
- Publisher Link
- http://dx.doi.org/10.1002/hep4.1334
- Publisher
- John Wiley & Sons
- Resource Type
- journal article
- Date
- 2019
- Description
- People with decompensated cirrhosis are often prescribed a complex regimen of therapeutic and prophylactic medications. In other chronic diseases, polypharmacy increases the risk of medication misadventure and medication‐related problems (MRPs), with associated increased morbidity, mortality, and health care costs. This study examined MRPs in a cohort of ambulatory patients with a history of decompensated cirrhosis who were enrolled in a randomized controlled trial of a pharmacist‐led, patient‐oriented medication education intervention and assessed the association between MRPs and patient outcomes. A total of 375 MRPs were identified among 57 intervention patients (median, 6.0; interquartile range, 3.5‐8.0 per patient; maximum 17). Nonadherence (31.5%) and indication issues (29.1%) were the most prevalent MRP types. The risk of potential harm associated with MRPs was low in 18.9% of instances, medium in 33.1%, and high in 48.0%, as categorized by a clinician panel using a risk matrix tool. Patients had a greater incidence rate of high‐risk MRPs if they had a higher Child‐Pugh score (incidence rate ratio [IRR], 1.31; 95% confidence interval [CI], 1.09‐1.56); greater comorbidity burden (IRR, 1.15; 95% CI, 1.02‐1.29); and were taking more medications (IRR, 1.12; 95% CI, 1.04‐1.22). A total of 221 MRPs (58.9%) were resolved following pharmacist intervention. A greater proportion of high‐risk MRPs were resolved compared to those of low and medium risk (68.9% versus 49.7%; P < 0.001). During the 12‐month follow‐up period, intervention patients had a lower incidence rate of unplanned admissions compared to usual care (IRR, 0.52; 95% CI, 0.30‐0.92). Conclusion: High‐risk MRPs are prevalent among adults with decompensated cirrhosis. Pharmacist intervention facilitated identification and resolution of high‐risk MRPs and was associated with reduced incidence rate of unplanned hospital admissions in this group.
- Subject
- cirrhosis; chronic diseases; polypharmacy; medication-related problems (MRPs)
- Identifier
- http://hdl.handle.net/1959.13/1420199
- Identifier
- uon:37550
- Identifier
- ISSN:2471-254X
- Rights
- © 2019 The Authors. Hepatology Communications published by Wiley Periodicals, Inc., on behalf of the American Association for the Study of Liver Diseases. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
- Language
- eng
- Full Text
- Reviewed
- Hits: 7566
- Visitors: 4463
- Downloads: 450
| Thumbnail | File | Description | Size | Format | |||
|---|---|---|---|---|---|---|---|
| View Details Download | ATTACHMENT02 | Publisher version (open access) | 493 KB | Adobe Acrobat PDF | View Details Download |